PT  - JOURNAL ARTICLE
AU  - Belma Haliloglu
AU  - Yasemin Gokdemir
AU  - Zeynep Atay
AU  - Saygin Abali
AU  - Tulay Guran
AU  - Fazilet Karakoc
AU  - Refika Ersu
AU  - Bulent Karadag
AU  - Serap Turan
AU  - Abdullah Bereket
TI  - Hypoglycemia: An unrecognized problem in cystic fibrosis (CF) patients unmasked by continues glucose monitorisation (CGM)
DP  - 2014 Sep 01
TA  - European Respiratory Journal
PG  - P1216
VI  - 44
IP  - Suppl 58
4099  - http://erj.ersjournals.com/content/44/Suppl_58/P1216.short
4100  - http://erj.ersjournals.com/content/44/Suppl_58/P1216.full
SO  - Eur Respir J2014 Sep 01; 44
AB  - Cystic Fibrosis Related Diabetes (CFRD) is one of the factors associated with increased mortality in CF. CGM has the potential to diagnose glucose abnormalities earlier than OGTT.Aim:To compare CGM vs standard OGTT in determining diabetes and other glucose abnormalities.Methods: 44 CF patients underwent OGTT followed by CGM for three days.The patients were classified according to OGTT categories and the CGM results.CGM results were grouped as hypoglycemia, hyperglycemia and both hypo and hyperglycemia.View this table:OGTT and CGM resultsResults: In 26 patients who had normal OGTT, CGM showed hyperglycemia in 7, both hypo-and hyperglycemia in 6, and hypoglycemia only in 1 patient. The frequency of hypoglycemia in OGTT was %13.6.Conclusion:CGM is a useful tool especially to determine hypoglycemia in CF patients which might be missed by OGTT. We suggest that CF patients should be evaluated by CGM especially if they are to be started/or on insulin treatment to detect and prevent hypoglycemia appropriately.